India, April 22 -- Shares of a recently listed specialty pharmaceutical exporter came into focus on Wednesday after the company disclosed, a commercial arrangement with an international entity for the marketing and sale of its pharmaceutical finished product portfolio. The announcement, filed directly by the Chairman and Managing Director, follows the company's BSE-SME listing on March 30, 2026 making this the first material order disclosure since its IPO, timed just 23 days after listing.

With a market capitalisation of Rs. 262.52 crore, the shares of Speciality Medicines Limited were trading at Rs. 298.8 per share, up 5 percent from its previous close of Rs.284.6.

The disclosure states that the company has finalised a commercial arran...